Camille L Bedrosian Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Camille L Bedrosian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Camille L Bedrosian. Camille L Bedrosian is VP, Chief Medical Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and EVP and Chief Medical Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX).
Camille L Bedrosian in Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Camille L Bedrosian: EVP and Chief Medical Officer
Holdings: 38,775 shares
Current Value: $2,827,085
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Camille L Bedrosian in Ultragenyx Pharmaceutical Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, CRNX, RYTM, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 113.67 | 364 | 41,376 | 38,775 | 39.1 K to 38.8 K (-0.93 %) |
Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | M | 55.00 | 5,000 | 275,000 | 58,000 | |
Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 109.09 | 5,000 | 545,450 | 39,139 | 44.1 K to 39.1 K (-11.33 %) |
Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Buy | M | 55.00 | 5,000 | 275,000 | 44,139 | 39.1 K to 44.1 K (+12.77 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 138.18 | 4,543 | 627,752 | 39,139 | 43.7 K to 39.1 K (-10.40 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 4,636 | 0 | 43,682 | 39 K to 43.7 K (+11.87 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 5,500 | 0 | 39,046 | 33.5 K to 39 K (+16.40 %) |
Feb 02 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 140.36 | 2,243 | 314,827 | 33,546 | 35.8 K to 33.5 K (-6.27 %) |
Jan 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | M | 55.00 | 25,000 | 1,375,000 | 63,000 | |
Jan 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 139.18 | 25,000 | 3,479,500 | 35,789 | 60.8 K to 35.8 K (-41.13 %) |
Jan 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Buy | M | 55.00 | 25,000 | 1,375,000 | 60,789 | 35.8 K to 60.8 K (+69.85 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 88.00 | 262 | 23,056 | 35,789 | 36.1 K to 35.8 K (-0.73 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 66.26 | 249 | 16,499 | 36,051 | 36.3 K to 36.1 K (-0.69 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | A | 56.08 | 21,000 | 1,177,680 | 21,000 | |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 56.08 | 1,249 | 70,044 | 36,300 | 37.5 K to 36.3 K (-3.33 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 5,634 | 0 | 37,549 | 31.9 K to 37.5 K (+17.65 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 7,300 | 0 | 31,915 | 24.6 K to 31.9 K (+29.66 %) |
Jan 31 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 53.23 | 1,624 | 86,446 | 24,615 | 26.2 K to 24.6 K (-6.19 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 1,437 | 0 | 26,239 | 24.8 K to 26.2 K (+5.79 %) |
May 07 2019 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 1,438 | 0 | 24,802 | 23.4 K to 24.8 K (+6.15 %) |
Feb 15 2019 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 48.85 | 1,636 | 79,919 | 16,364 | 18 K to 16.4 K (-9.09 %) |
Jan 31 2018 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | A | 55.00 | 88,000 | 4,840,000 | 88,000 | |
Jan 31 2018 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Page: 1